a psa pyramid for men with initial prostate-specific antigen ≤3 ngml a plea for individualized prostate cancer screening:一个男人最初的前列腺特异性抗原≤3 ngml一个性化筛选前列腺癌psa金字塔抗辩.pdfVIP

a psa pyramid for men with initial prostate-specific antigen ≤3 ngml a plea for individualized prostate cancer screening:一个男人最初的前列腺特异性抗原≤3 ngml一个性化筛选前列腺癌psa金字塔抗辩.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a psa pyramid for men with initial prostate-specific antigen ≤3 ngml a plea for individualized prostate cancer screening:一个男人最初的前列腺特异性抗原≤3 ngml一个性化筛选前列腺癌psa金字塔抗辩

E U R O P E A N U R O L O G Y 6 8 ( 2 0 1 5 ) 5 9 1 – 5 9 7 ava ilable at journal homepage: www.eu Platinum Priority – Prostate Cancer Editorial by Daniel D. Sjoberg on pp. 598–599 of this issue A ‘‘PSA Pyramid’’ for Men with Initial Prostate-specific Antigen =3 ng/ml: A Plea for Individualized Prostate Cancer Screening Marco Randazzo a, *, Josef Beatrice a, Andreas Huber b, Rainer Grobholz c, Lukas Manka d, Felix K. Chun e, Franz Recker a, Maciej Kwiatkowski a,d a Department of Urology, Cantonal Hospital Aarau, Aarau, Switzerland; b Department of Laboratory Medicine, Cantonal Hospital Aarau, Aarau, Switzerland; c Department of Pathology, Cantonal Hospital Aarau, Aarau, Switzerland; d Department of Urology, Academic Hospital Braunschweig, Braunschweig, Germany; e Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany Article info Abstract Article history: Background: In daily routine business, various prostate-specific antigen (PSA) retest Accepted April 9, 2014 strategies are being promoted. Published online ahead of Objective: To investigate rescreening intervals according to baseline PSA 3 ng/ml stratified by any and aggressive prostate cancer (PCa). print on April 18, 2014 Design, setting, and participants: From 1998 to 2012, data from 4350 men aged 55–70 yr were analyzed from a population-based prospective screening study (median follow- Keywords: up: 11.6 yr). Early detection Outcome measurements and statistical analysis: The primary end point was detection

您可能关注的文档

文档评论(0)

ajgoaw + 关注
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档